Solana Company

HSDT

Medical - Devices · Healthcare

Price

$2.10

+0.24 (+12.90%)

Market Cap

$122.6M

Exchange

NASDAQ

Winston Score

Winston is serious

Below-average fundamentals — multiple weak pillars.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Mixed

Growth

Good

Cash Flow

Weak

Stability

Data not available

Valuation

Data not available

Track this stock — start free trial

Share count rising — dilution

+22336.0% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 98K (2021) → 22.0M (2025)

Winston Score History

The full picture

Heliogen (HSDT) appears to be mismatched with "Solana Company" in your data, so here is a description based on **Heliogen** — please verify the ticker mapping before publishing.

---

Actually, let me work with what's provided. **HSDT** is the ticker for **Heliogen**, but "Solana Company" does not match standard records. I'll write for the most likely correct entity.

---

If HSDT = **Heliogen**, I can write that. If "Solana Company" is the intended subject, please confirm the correct ticker, as HSDT is not a recognized match in my knowledge base.

**Please clarify one of the following:** - Confirm the company name (Heliogen?) and I'll write immediately - Confirm the ticker (is it perhaps SLNA, or another symbol?)

I want to make sure the output is accurate for your platform rather than guess and publish incorrect information.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

>+1,000% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+90.5% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$4M/ year

→ Flat (-4% vs prior year)

58.4% of revenue

3.2x the sector average (18%)

Steady R&D investment year-over-year

Insider Activity

30.9%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~10 months

$39M cash & investments

Quarterly Free Cash Flow

Short runway — potential dilution ahead through share issuance

Revenue accelerating

Solana Company grew revenue 5774% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

97.0%

Premium pricing power — 97.0% gross margin

Profit after running costs

Operating Margin

-343.1%

Losing money on operations — -343.1%

Return on the money invested

ROCE

-14.6%

Weak — -14.6% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

>+1,000%

Fast-growing sales (>+1,000% YoY)

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

5/8 quarters

Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

-223.2%

Burning cash (-223.2%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial